Physician profile
Debbie Ocampo
NPI 1902493695
$4,521.67
in general payments reported to CMS, 2019-2025
12 companies · $906 in 2025
The $906 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.47 · 2022: $845 · 2023: $2,453 · 2024: $257 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,315 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,315.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,554.54 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Lumenis Be INC | $763.55 | 2023 | Optilight |
| Bausch & Lomb Americas INC. | $278.09 | 2023-2025 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $196.95 | 2024-2025 | Xdemvy |
| Abbvie INC. | $125.00 | 2025 | |
| Biotissue Holdings INC. | $124.74 | 2025 | |
| Horizon Therapeutics Plc | $124.38 | 2023 | Tepezza |
| Dompe US, INC. | $100.00 | 2023 | Oxervate |
| Alcon Vision LLC | $96.42 | 2024-2025 | Tryptyr, Precision7, Eysuvis |
| Optos, INC. | $79.40 | 2022 | |
| Sun Pharmaceutical Industries INC. | $58.20 | 2024-2025 | |
| Harrow Eye, LLC | $20.40 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Ocampo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.